Filings

3 documents · 5 matches

1. RGBP Regen BioPharma Inc 10-K 2025-12-30

   Item 9A. Controls and Procedures

   material weaknesses, our financial statements for the year ended September 30, 2024 are fairly stated, in all material respects, in accordance
   2 matches in this document Show context Copy citation

2. RGBP Regen BioPharma Inc 10-K 2025-05-13

   Item 9A. Controls and Procedures

   material weaknesses, our financial statements for the year ended September 30, 2024 are fairly stated, in all material respects, in accordance
   2 matches in this document Show context Copy citation

3. RGBP Regen BioPharma Inc 8-K 2026-07-15

   Item 4.01. Changes in Registrant’s Certifying Accountant

   material weaknesses in the Company’s internal control over financial reporting previously disclosed under Part II, Item 9A of the Company
   1 match in this document Show context Copy citation